Table 2.
Intermediate outcomes | Prescribing | ||||
---|---|---|---|---|---|
Manual | Non-manual | Manual | Non-manual | ||
BP ≤ 145/85 mmHg | Anti‐hypertensives | ||||
% | 2003 | 65.9 | 60.3 | 52.8 | 47.1 |
AOR | 1.32(0.86–2.02) | 1 | 1.27(0.90–1.77) | 1 | |
% | 2006 | 67.6 | 69.7 | 52.1 | 47.0 |
AOR | 0.88(0.55–1.42) | 1 | 1.10(0.85–1.42) | 1 | |
Cholesterol ≤ 5 mmpl/L | Lipid-lowering agents | ||||
% | 2003 | 52.5 | 46.6 | 43.4 | 37.2 |
AOR | 1.13(0.68–1.87) | 1 | 1.30(0.87–1.91) | 1 | |
% | 2006 | 68.7 | 70.5 | 66.2 | 65.3 |
AOR | 0.86(0.48–1.54) | 1 | 0.96(0.70–1.31) | 1 | |
HbA1c ≤ 7.5% | OHAs | ||||
% | 2003 | 55.7 | 71.2 | 63.5 | 59.4 |
AOR | 0.47(0.28–0.80) | 1 | 1.18(0.84–1.66) | 1 | |
% | 2006 | 59.7 | 68.3 | 71.4 | 61.7 |
AOR | 0.66(0.37–1.15) | 1 | 1.34(0.68–1.23) | 1 |
AOR – adjusted odds ratio; OHAs – oral hypoglycaemic agents